KEGG   DRUG: Trastuzumab duocarmazine
Entry
D11375                      Drug                                   
Name
Trastuzumab duocarmazine (USAN/INN)
Class
Antineoplastic
 DG01918  Tyrosine kinase inhibitor
  DG01917  Receptor tyrosine kinase inhibitor
   DG03158  HER2 inhibitor
Remark
ATC code: L01FD05
Efficacy
Antineoplastic, Alkylating agent, Receptor tyrosine kinase inhibitor, Anti-HER2 antibody
Comment
Antibody-drug conjugate
Target
ERBB2 (HER2, CD340) [HSA:2064] [KO:K05083]
DNA
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01F MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
     L01FD05 Trastuzumab duocarmazine
      D11375  Trastuzumab duocarmazine (USAN/INN)
Drug groups [BR:br08330]
 Antineoplastic
  DG01918  Tyrosine kinase inhibitor
   DG01917  Receptor tyrosine kinase inhibitor
    DG03158  HER2 inhibitor
     D11375  Trastuzumab duocarmazine
Target-based classification of drugs [BR:br08310]
 Protein kinases
  Receptor tyrosine kinases (RTK)
   EGFR family
    ERBB2 (HER2, CD340)
     D11375  Trastuzumab duocarmazine (USAN/INN)
Other DBs
CAS: 1642152-40-6
PubChem: 384585353
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system